![Mathieu Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 543 345 $ al 31/05/2026
El Dr. Mathieu Simon es presidente de Epsilen Bio SRL, presidente de Idorsia Ltd., director independiente de Asarina Pharma AB, director independiente de Vaximm AG, presidente de Idorsia Pharmaceuticals Ltd., director general de Cellectis Therapeutics y director independiente de LNC Therapeutics SA. Forma parte del Consejo de Administración de Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associs SCA y LNC Therapeutics SA. Anteriormente, el Dr. Simon fue vicepresidente ejecutivo, director de operaciones y médico de Cellectis SA, vicepresidente de marketing y asuntos médicos de Wyeth Pharmaceuticals LLC, vicepresidente del grupo de marketing y asuntos clínicos de Wyeth-Ayerst International, Inc. y vicepresidente sénior de operaciones globales de Pierre Fabre Mdicament SAS, director general y jefe de farmacia global de Pierre Fabre SA, y presidente y director ejecutivo de Takara Bio Europe AB. También formó parte del consejo de Alliance for Regenerative Medicine, Ectycell SASU y Farmindustria.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IDORSIA LTD. 0,04 % | 31/12/2024 | 95.061 ( 0,04 % ) | 543 345 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IDORSIA LTD | Director/Miembro de la Junta | 13/06/2024 |
Aileens Pharma Srl
 Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Presidente | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Presidente | 13/05/2020 |
Messier Maris & Associés SCA
 Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Director/Miembro de la Junta | - |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Presidente | 15/06/2020 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Director/Miembro de la Junta | 01/01/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| AFFIMED N.V. | Director/Miembro de la Junta | 26/06/2024 |
| CELLECTIS S.A. | Director Técnico/Científico/I+D | 14/03/2018 |
Cellectis Therapeutics | Director Ejecutivo | 01/02/2014 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 22 |
|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Health Technology |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Université Paris Diderot-Paris 7
 Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Messier Maris & Associés SCA
Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Finance |
Ectycell SASU
 Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Health Technology |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
Wyeth-Ayerst International LLC | |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Operates as a healthcare organization | Commercial Services |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Aileens Pharma Srl
Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Health Technology |
Cellectis Therapeutics |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
